Home LiteratureArticle Details
PMID: 28977875 Published · epublish English Journal Article

Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma.

Oncotarget ·Vol. 8 ·No. 37 ·2017-09-22 ·Pages 61425-61439

Yang ZZ, Kim HJ, Villasboas JC, Chen YP, Price-Troska T, Jalali S, Wilson M, Novak AJ, Ansell SM

Abstract

Exhausted T-cells in follicular lymphoma (FL) typically express PD-1, but expression of PD-1 is not limited to exhausted cells. Although expected to be functionally suppressed, we found that the population of intratumoral PD-1+ T cells were predominantly responsible for production of cytokines and granules. This surprising finding prompted us to explore the involvement of LAG-3 to specifically identify functionally exhausted T cells. We found that LAG-3 was expressed on a subset of intratumoral T cells from FL and LAG-3+ T cells almost exclusively came from PD-1+ population. CyTOF analysis revealed that intratumoral LAG-3+ T cells were phenotypically heterogeneous as LAG-3 was expressed on a variety of T cell subsets. In contrast to PD-1+LAG-3- cells, intratumoral PD-1+LAG-3+ T cells exhibited reduced capacity to produce cytokines and granules. LAG-3 expression could be substantially upregulated on CD4+ or CD8+ T cells by IL-12, a cytokine that has been shown to induce T-cell exhaustion and be increased in the serum of lymphoma patients. Furthermore, we found that blockade of both PD-1 and LAG-3 signaling enhanced the function of intratumoral CD8+ T cells resulting in increased IFN-γ and IL-2 production. Clinically, LAG-3 expression on intratumoral T cells correlated with a poor outcome in FL patients. Taken together, we find that LAG-3 expression is necessary to identify the population of intratumoral PD-1+ T cells that are functionally exhausted and, in contrast, find that PD-1+LAG-3- T cells are simply activated cells that are immunologically functional. These findings may have important implications for immune checkpoint therapy in FL.

Keywords
LAG-3 PD-1 T-cell exhaustion follicular lymphoma immune checkpoint
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Yang Zhi-Zhang
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Kim Hyo Jin
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Villasboas Jose C
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Chen Ya-Ping
Division of Oncology/Hematology and Internal Medicine, College of Medicine, National Cheng Kung University and Hospital, Tainan, Taiwan.
Price-Troska Tammy
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Jalali Shahrzad
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Wilson Mara
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Novak Anne J
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Ansell Stephen M
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Conflict of Interest

CONFLICTS OF INTEREST The authors declare no competing financial interests.

References (30)
30 references, click to expand
  1. CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins.
    Eur J Immunol. 1995 Sep;25(9):2718-21 PMID: 7589152
  2. LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.
    J Thorac Oncol. 2017 May;12 (5):814-823 PMID: 28132868
  3. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.
    J Virol. 2010 Feb;84(4):2078-89 PMID: 19955307
  4. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
    Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7875-80 PMID: 20385810
  5. PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival.
    Blood Cancer J. 2015 Feb 20;5:e281 PMID: 25700246
  6. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.
    Nat Immunol. 2009 Jan;10(1):29-37 PMID: 19043418
  7. Expression and release of LAG-3-encoded protein by human CD4+ T cells are associated with IFN-gamma production .
    FASEB J. 1996 May;10(7):769-76 PMID: 8635694
  8. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.
    J Clin Oncol. 2007 Feb 1;25(4):390-8 PMID: 17200149
  9. Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II.
    Immunogenetics. 1998 Jul;48(2):116-24 PMID: 9634475
  10. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy.
    Oncotarget. 2017 Jun 13;8(24):38850-38862 PMID: 28418918
  11. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.
    N Engl J Med. 2004 Nov 18;351(21):2159-69 PMID: 15548776
  12. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity.
    J Exp Med. 2010 Sep 27;207 (10 ):2187-94 PMID: 20819927
  13. The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells.
    Immunology. 2005 Jun;115(2):170-8 PMID: 15885122
  14. IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma.
    J Clin Invest. 2012 Apr;122(4):1271-82 PMID: 22426209
  15. The new B7s: playing a pivotal role in tumor immunity.
    J Immunother. 2007 Apr;30(3):251-60 PMID: 17414316
  16. Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer.
    Clin Cancer Res. 2015 Jul 1;21(13):3031-40 PMID: 25688160
  17. The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects.
    J Immunol. 2015 Apr 15;194(8):3873-82 PMID: 25780040
  18. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
    Nature. 2006 Sep 21;443(7109):350-4 PMID: 16921384
  19. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity.
    J Immunol Methods. 2001 Jul 1;253(1-2):177-87 PMID: 11384679
  20. PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.
    J Clin Invest. 2014 May;124(5):2246-59 PMID: 24667641
  21. Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells.
    J Exp Med. 2001 Jun 18;193(12):1373-81 PMID: 11413192
  22. Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma.
    Cancer Res. 2006 Oct 15;66(20):10145-52 PMID: 17047079
  23. Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.
    Cancer Res. 2012 Feb 15;72(4):917-27 PMID: 22186141
  24. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
    Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14733-8 PMID: 20679213
  25. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
    J Immunol. 2007 Aug 1;179(3):1979-87 PMID: 17641065
  26. PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro.
    PLoS One. 2015 Sep 11;10(9):e0136476 PMID: 26361042
  27. TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphoma.
    Leukemia. 2014 Sep;28(9):1872-84 PMID: 24569779
  28. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production.
    J Exp Med. 2000 Dec 4;192(11):1545-52 PMID: 11104797
  29. Role of LAG-3 in regulatory T cells.
    Immunity. 2004 Oct;21(4):503-13 PMID: 15485628
  30. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.
    J Exp Med. 2000 Dec 4;192(11):1553-62 PMID: 11104798
Article Info
Journal
Oncotarget
Abbr.
Oncotarget
ISSN
1949-2553
Published
2017-09-22
Epub
2017-00-29
Pages
61425-61439
Language
English
Region
United States
NLM ID
101532965
PMCID
PMC5617435
Grants
NCI NIH HHS · P50 CA097274 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com